BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Michael J. Nowak Has Recently Joined Ferghana Partners as Director to Focus on Financing Activities


2/15/2013 10:34:51 AM

Ferghana Partners Group [New York, Boston, London], the international provider of high level, independent corporate finance advice to firms in the Biotechnology, Pharmaceuti- cals, Diagnostics and Specialty Chemicals industries, is pleased to announce that Michael J. Nowak has recently joined its teams as Director to focus heavily on Financing activities [private placement and PIPEs]. Michael brings over twenty years of experience in both early and late stage financing of innovative high science and technology compa- nies. He has led over three dozen financings in public Life Sciences companies listed on over ten stock exchanges around the world during the last four years for a large US- based hedge fund.

“We welcome Michael’s experience, creativity and Financing expertise,” said Bill Kridel, Managing Director and Founder of Ferghana Partners.

Prior to this appointment, Michael was a General Partner at TVM Capital, a billion dollar Euro-US venture capital fund. He also has entrepreneurial, business development and investment experience from work as a co-founder of the Xerox Venture Lab at the Xerox Palo Alto Research Center (PARC), as a VP Business Development for the emerging high tech consulting practice at McKinsey & Co., and as a Program Manager of two $100M+ investment programs at the Advanced Technology Program at the National Institute of Standards and Technology (NIST), US Department of Commerce.

Michael earned an MBA from the Wharton School at the University of Pennsylvania in Finance and Strategic Management and a PhD in Physics from the University of Califor- nia, Santa Barbara. He worked as a post-doctoral scientist at Bell Labs (Bellcore), Princeton University, and at the CEA research labs in Saclay, France. He received his BA in Physics from Cornell University in Ithaca, NY, where he was a College Scholar.



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES